Partner Content Partner Content 4th Annual Genome Editing USA Congress 2 days, 350+ end users, 80+ case studies
Partner Content Partner Content Maximising Virtual Advisory Board Platforms How to maximise use of Virtual Advisory Boards
Partner Content Partner Content Tracking Your KOL Activities The easier way to track and manage your KOL activities
Partner Content Partner Content Summarising & Combining Insights Highlight, prioritize & combine your MSL insights
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
